Related Experiment Video
Updated: Jun 24, 2026
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Mesenteric Fibromatosis Mimicking Metastasis of Neuroendocrine Tumor on 18 F-AlF-NOTA-Octreotide PET/CT and Contrast-
Jiapeng Zhuang1, Guangchong Zhao1, Yiyin Lu2
1Department of Nuclear Medicine, The First Affiliated Hospital of Dalian Medical University.
Abstract:
A 52-year-old man with a prior history of resected G2 pancreatic neuroendocrine tumor presented with a newly identified abdominal mass during 17-month follow-up. Contrast-enhanced MRI depicted a heterogeneously hyper-enhancing jejunal mesenteric lesion, highly suggestive of metastatic disease. ¹⁸F-AlF-NOTA-Octreotide PET/CT revealed mild tracer accumulation within the lesion, which was initially interpreted as NET metastasis. Surgical pathology ultimately confirmed mesenteric fibromatosis. This case emphasizes an important diagnostic trap, as benign fibromatosis can mimic NET metastasis on both anatomic and SSTR-targeted PET imaging, alerting clinicians to avoid misdiagnosis and unnecessary treatment.
